文献速递妇科

宫颈上皮内瘤变不完全切除作为复发风险预测因素:一项16年随访研究

Incomplete excision of cervical intraepithelial neoplasia as a predictor of the risk of recurrent disease-a 16-year follow-up study.
PubMed 文献 · Am J Obstet Gynecol · 2019-08-29

该前瞻性研究纳入991例2000-2007年因宫颈上皮内瘤变2/3行锥切术的女性,随访中位10年、最长16年,发现切缘阳性/不确定者残留/复发高级别宫颈上皮内瘤变或更差的风险高于切缘阴性者(HR 2.67,95%CI 1.81-3.93),风险随切缘解剖位置而异,合并症也是独立预测因素。

要点

  • 切缘阳性/不确定者残留/复发高级别宫颈上皮内瘤变或更差风险为切缘阴性者的2.67倍(95%CI 1.81-3.93)。
  • 切缘阳性/不确定者中,内切缘阳性者HR 2.72(95%CI 1.67-4.41),内+外切缘均阳性者HR 4.98(95%CI 2.85-8.71)。
  • 仅外切缘阳性或不确定时风险未显著增加;合并症是独立预测因素。

核心结论

  • 宫颈上皮内瘤变2/3不完全切除的患者残留/复发高级别宫颈上皮内瘤变或更差的风险增加。
  • 切缘状态结合高危人乳头瘤病毒结果并考虑合并症可能提高预测治疗失败的准确性。

研究设计与样本

  • 前瞻性研究纳入991例组织病理学确诊的宫颈上皮内瘤变2/3且于2000-2007年行锥切术的女性。
  • 信息来自瑞典国家宫颈筛查登记处和医疗记录,中位随访10年、最长16年。
  • 采用Kaplan-Meier曲线绘制累积发病率,Cox回归评估决定因素。

主要发现

  • 随访期间111例患者诊断为残留/复发高级别宫颈上皮内瘤变或更差。
  • 调整潜在混杂因素后,切缘阳性/不确定者残留/复发高级别宫颈上皮内瘤变或更差的风险高于切缘阴性者(HR 2.67,95%CI 1.81-3.93)。
  • 风险随切缘解剖位置而异:内切缘阳性者HR 2.72(95%CI 1.67-4.41),内+外切缘均阳性者HR 4.98(95%CI 2.85-8.71)。
  • 仅外切缘阳性或不确定时风险未显著增加。
  • 合并症(自身免疫病、人类免疫缺陷病毒感染、乙型和/或丙型肝炎、恶性肿瘤、糖尿病、遗传性疾病和/或器官移植)也是残留/复发高级别宫颈上皮内瘤变或更差的显著独立预测因素。

关键数值与推荐

  • 切缘阳性/不确定者残留/复发高级别宫颈上皮内瘤变或更差风险为切缘阴性者的2.67倍(HR 2.67,95%CI 1.81-3.93)。
  • 内切缘阳性者HR 2.72(95%CI 1.67-4.41),内+外切缘均阳性者HR 4.98(95%CI 2.85-8.71)。
  • 仅外切缘阳性或不确定时风险未显著增加。
  • 随访中高危人乳头瘤病毒阳性且切缘阳性/不确定者的残留/复发高级别宫颈上皮内瘤变或更差风险,显著高于高危人乳头瘤病毒阳性但切缘阴性者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Women treated for high-grade cervical intraepithelial neoplasia (grade 2 or 3) are at elevated risk for developing cervical cancer. Suggested factors identifying women at highest risk for recurrence post-therapeutically include incomplete lesion excision, lesion location, size and severity, older age, treatment modality, and presence of high-risk human papilloma virus after treatment. This question has been intensively investigated over decades, but there is still substantial debate as to which of these factors or combination of factors most accurately predict treatment failure. OBJECTIVE: In this study, we examine the long-term risk of residual/recurrent high-grade cervical intraepithelial neoplasia among women previously treated for cervical intraepithelial neoplasia 2/3 and how this varies according to margin status (considering also location), as well as comorbidity (conditions assumed to interact with high-risk human papilloma virus acquisition and/or cervical intraepithelial neoplasia progression), posttreatment presence of high-risk human papilloma virus, and other factors. MATERIALS AND METHODS: This prospective study included 991 women with histopathologically confirmed cervical intraepithelial neoplasia 2/3 who underwent conization in 2000-2007. Information on the primary histopathologic finding, treatment modality, comorbidity, age, and high-risk human papilloma virus status during follow-up, and residual/recurrent high-grade cervical intraepithelial neoplasia was obtained from the Swedish National Cervical Screening Registry and medical records. Cumulative incidence of residual/recurrent high-grade cervical intraepithelial neoplasia was plotted on Kaplan-Meier curves, with determinants assessed by Cox regression. RESULTS: During a median of 10 years and maximum of 16 years of follow-up, 111 patients were diagnosed with residual/recurrent high-grade cervical intraepithelial neoplasia or worse. Women with positive/uncertain margins had a higher risk of residual/recurrent high-grade cervical intraepithelial neoplasia or worse than women with negative margins, adjusting for potential confounders (hazard ratio, 2.67; 95% confidence interval, 1.81-3.93). The risk of residual/recurrent high-grade cervical intraepithelial neoplasia or worse varied by anatomical localization of the margins (endocervical: hazard ratio, 2.72; 95% confidence interval, 1.67-4.41) and both endo- and ectocervical (hazard ratio, 4.98; 95% confidence interval, 2.85-8.71). The risk did not increase significantly when only ectocervical margins were positive or uncertain. The presence of comorbidity (autoimmune disease, human immunodeficiency viral infection, hepatitis B and/or C, malignancy, diabetes, genetic disorder, and/or organ transplant) was also a significant independent predictor of residual/recurrent high-grade cervical intraepithelial neoplasia or worse. In women with positive high-risk human papilloma virus findings during follow-up, the hazard ratio of positive/uncertain margins for recurrent/residual high-grade cervical intraepithelial neoplasia or worse increased significantly compared to that in women with positive high-risk human papilloma virus findings but negative margins. CONCLUSION: Patients with incompletely excised cervical intraepithelial neoplasia 2/3 are at increased risk for residual/recurrent high-grade cervical intraepithelial neoplasia or worse. Margin status combined with high-risk human papilloma virus results and consideration of comorbidity may increase the accuracy for predicting treatment failure.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Alder S, Megyessi D, Sundström K, et al. Incomplete excision of cervical intraepithelial neoplasia as a predictor of the risk of recurrent disease-a 16-year follow-up study. Am J Obstet Gynecol. 2019. PMID: 31473226. doi:10.1016/j.ajog.2019.08.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。